|
Mesothelioma Article Archives 2003
WA Team's Mesothelioma Breakthrough
Decenber 17, 2003
A new study provides promising results on a blood test to identify people with mesothelioma. Mesothelioma is a deadly tumor of mesothelial tissue surrounding the lungs, often caused by exposure to asbestos.
November 14, 2003
Eli Lilly and Company: 1,000th U.S. Patient Enrolls in Alimta -- pemetrexed -- Expanded Access Program
October 8, 2003
Eli Lilly and Company: Fewer Side Effects Reduce Costly Supportive Care for Non-Small Cell Lung Cancer Patients
September 24, 2003
Drug developed for rare disease may help millions more as treatment for cancer, autoimmune diseases
September 10, 2003
Antisense oligonucleotides chemosensitize mesothelioma cells in culture
August 15, 2003
Phase I Study of SS1(dsFv)-PE38 Immunotoxin in Patients With Advanced Mesothelin-Expressing Malignancies
July 26, 2003
Phase I Study of Intrapleural BG00001 in Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions
July 26, 2003
Pemetrexed plus cisplatin "makes a difference" in mesothelioma survival
July 22, 2003
Combination
Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced,
Metastatic, or Recurrent Non-Small Cell Lung Cancer
May 30, 2003
Study of Pemetrexed With and Without Folic Acid and Vitamin B12 as Front-Line Therapy in Malignant Pleural Mesothelioma
April 15, 2003
SV40-Contaminated Poliovirus Not Associated with Cancer Risk
April 1, 2003
Bevacizumab,
Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage IB,
Stage II, or Stage IIIA Non-Small Cell Lung Cancer
May 30, 2003
Trial
of Avastin and Tarceva for Locally Advanced or Metastatic Non-Squamous
Non-Small-Cell Lung Cancer in Previously Treated Patients
May 30, 2003
Phase II Study of Alanosine in Patients With Methylthioadenosine Phosphorylase (MTAP)-Deficient Cancer
May 23, 2003
U.S. Gov't Issues Warning on Asbestos in Insulation
May 22, 2003
Some response to raltitrexed seen in malignant pleural mesothelioma
March 25, 2003
| MIRG.org 1-888-802-6376 e-mail |  |
|
|
•
•
•
•
•
|
Mesothelioma Information
Resource Group, MIRG.org, tries to assist individuals and families in learning about mesothelioma and other asbestos related injuries. It is the aim of MIRG.org to provide an account of the disease mesothelioma, its causes, various treatment options and potential legal impact. To find out more about Mesothelioma and other asbestos related diseases, new medical advances, and clinical trials now available please use the links provided.
The information on this website is presented by the Mesothelioma Information Resource Group and is for informational purposes only.
No particular course of treatment is suggested. All persons are advised to consult with a medical doctor concerning treatment of
mesothelioma or any illness. Also, nothing on this website is intended to constitute legal advice by a lawyer or attorney. Note disclaimer.
|
